Celon Pharma S.A. (WSE:CLN)
Poland flag Poland · Delayed Price · Currency is PLN
25.00
-1.15 (-4.40%)
Apr 4, 2025, 2:44 PM CET

Celon Pharma Ratios and Metrics

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2014 - 2018
Period Ending
Apr '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2014 - 2018
Market Capitalization
1,4087897161,6911,8251,787
Upgrade
Market Cap Growth
86.15%10.32%-57.68%-7.35%2.14%27.04%
Upgrade
Enterprise Value
1,3197045781,4871,8071,710
Upgrade
Last Close Price
26.1515.3813.8732.2039.3138.39
Upgrade
PE Ratio
74.99----149.69
Upgrade
Forward PE
25.64---51.0147.55
Upgrade
PS Ratio
6.623.693.698.6211.5917.47
Upgrade
PB Ratio
2.731.771.493.055.304.01
Upgrade
P/TBV Ratio
2.871.831.563.215.964.03
Upgrade
P/FCF Ratio
--650.25--
Upgrade
P/OCF Ratio
--38.4725.44-
Upgrade
EV/Sales Ratio
6.303.292.987.5911.4816.73
Upgrade
EV/EBITDA Ratio
21.1681.54-53.4270.9063.72
Upgrade
EV/EBIT Ratio
60.32----275.05
Upgrade
EV/FCF Ratio
-40.20--572.04--
Upgrade
Debt / Equity Ratio
0.030.060.060.030.070.00
Upgrade
Debt / EBITDA Ratio
0.231.245.920.521.000.06
Upgrade
Debt / FCF Ratio
---5.74--
Upgrade
Asset Turnover
0.350.350.290.320.280.18
Upgrade
Inventory Turnover
2.242.062.152.321.231.42
Upgrade
Quick Ratio
2.141.891.702.950.754.33
Upgrade
Current Ratio
2.672.202.043.231.055.53
Upgrade
Return on Equity (ROE)
3.79%-6.08%-7.60%-2.58%-0.23%2.67%
Upgrade
Return on Assets (ROA)
2.29%-2.92%-3.51%-1.07%-0.46%0.67%
Upgrade
Return on Capital (ROIC)
2.71%-3.62%-4.41%-1.41%-0.63%0.87%
Upgrade
Return on Capital Employed (ROCE)
4.00%----1.10%
Upgrade
Earnings Yield
1.31%-3.56%-5.49%-0.69%-0.05%0.67%
Upgrade
FCF Yield
-2.33%-5.21%-5.40%0.15%-1.52%-3.92%
Upgrade
Dividend Yield
0.31%0.52%0.65%0.90%0.18%0.21%
Upgrade
Payout Ratio
24.82%----60.33%
Upgrade
Buyback Yield / Dilution
-4.00%-0.04%-9.32%-3.74%--
Upgrade
Total Shareholder Return
-3.69%0.48%-8.67%-2.84%0.18%0.21%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.